Pai Holdings Company Profile
✉ Email this page to a colleague
What is the competitive landscape for PAI HOLDINGS, and what generic and branded alternatives to PAI HOLDINGS drugs are available?
PAI HOLDINGS has forty-nine approved drugs.
Drugs and US Patents for Pai Holdings
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pai Holdings | MIDAZOLAM HYDROCHLORIDE | midazolam hydrochloride | INJECTABLE;INJECTION | 078141-002 | May 30, 2008 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Pai Holdings Pharm | VANCOMYCIN HYDROCHLORIDE | vancomycin hydrochloride | CAPSULE;ORAL | 065478-001 | Apr 9, 2012 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Pai Holdings Pharm | GABAPENTIN | gabapentin | SOLUTION;ORAL | 211330-001 | Dec 3, 2019 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Pai Holdings
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Pai Holdings Pharm | ZANTAC IN PLASTIC CONTAINER | ranitidine hydrochloride | INJECTABLE;INJECTION | 019593-001 | Dec 17, 1986 | 4,521,431*PED | ⤷ Try a Trial |
Pai Holdings Pharm | ZANTAC IN PLASTIC CONTAINER | ranitidine hydrochloride | INJECTABLE;INJECTION | 019593-002 | Sep 27, 1991 | 4,585,790*PED | ⤷ Try a Trial |
Pai Holdings Pharm | ZANTAC | ranitidine hydrochloride | INJECTABLE;INJECTION | 019090-001 | Oct 19, 1984 | 4,585,790*PED | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.